Aim: To evaluate the clinical impact of corticosteroids (CS) overuse in inflammatory bowel disease (IBD) patients. Excessive use of CS could delay more efficacious treatment and may indicate poor quality of care.
Method: This is a two-phase study that used Steroid Assessment Tool (SAT) to measure corticosteroid exposure in IBD patients.